Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ruhcha V, Sutavani"'
Autor:
Chuan Wang, Nur Syafinaz Zainal, San Jiun Chai, James Dickie, Chai Phei Gan, Natasha Zulaziz, Bryan Kit Weng Lye, Ruhcha V. Sutavani, Christian H. Ottensmeier, Emma V. King, Mannil Thomas Abraham, Siti Mazlipah binti Ismail, Shin Hin Lau, Thomas George Kallarakkal, Kein Seong Mun, Rosnah binti Zain, Zainal Ariff Abdul Rahman, Gareth J. Thomas, Sok Ching Cheong, Natalia Savelyeva, Kue Peng Lim
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
HPV-independent head and neck squamous cell carcinoma (HNSCC) is a common cancer globally. The overall response rate to anti-PD1 checkpoint inhibitors (CPIs) in HNSCC is ~16%. One major factor influencing the effectiveness of CPI is the level of tumo
Externí odkaz:
https://doaj.org/article/4e3b57700cad491b8b3126170d014e2b
Autor:
Chuan Wang, James Dickie, Ruhcha V. Sutavani, Catherine Pointer, Gareth J. Thomas, Natalia Savelyeva
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Head and neck cancer (HNC) is a heterogeneous group of squamous cell cancers that affect the oral cavity, pharynx, and larynx. Worldwide, it is the sixth most common cancer but in parts of Southern and South-East Asia, HNC is one of the most common c
Externí odkaz:
https://doaj.org/article/fabb7b9624594ff18001330dc91e646e
Autor:
Catherine Pointer, Gareth J. Thomas, Ruhcha V. Sutavani, James Dickie, Natalia Savelyeva, Chuan Wang
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Frontiers in Immunology
Head and neck cancer (HNC) is a heterogeneous group of squamous cell cancers that affect the oral cavity, pharynx, and larynx. Worldwide, it is the sixth most common cancer but in parts of Southern and South-East Asia, HNC is one of the most common c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a305bd52211132ae6950a1aa64f0c46d
https://doi.org/10.3389/fimmu.2018.00830
https://doi.org/10.3389/fimmu.2018.00830
Autor:
Ruhcha V. Sutavani, Sok Ching Cheong, Chai Phei Gan, Chuan Wang, Natasha Zulaziz, Emma King, San Jiun Chai, Syafinaz Zainal, Kue Peng Lim, Natalia Savelyeva, Bryan Kit Weng Lye, Gareth J. Thomas, Christian H. Ottensmeier
Publikováno v:
Cancer Research. 79:1466-1466
The use of checkpoint inhibitor anti-PD1 has achieved significant clinical benefit, in recurrent and metastatic head and neck cancer patients, where the overall response rate is between 16-20%. The use of antigen-specific cancer vaccine to increase t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::876b632319a0f96056aec1705cacfa36
https://doi.org/10.1158/1538-7445.am2019-1466
https://doi.org/10.1158/1538-7445.am2019-1466
Autor:
Morisada, Hayakawa, Hiroko, Hayakawa, Tsvetana, Petrova, Patcharee, Ritprajak, Ruhcha V, Sutavani, Guillermina Yanek, Jiménez-Andrade, Yasuyo, Sano, Min-Kyung, Choo, John, Seavitt, Ram K C, Venigalla, Kinya, Otsu, Katia, Georgopoulos, J Simon C, Arthur, Jin Mo, Park
Publikováno v:
The Journal of Biological Chemistry
The evolutionarily conserved protein kinase p38 mediates innate resistance to environmental stress and microbial infection. Four p38 isoforms exist in mammals and may have been co-opted for new roles in adaptive immunity. Murine T cells deficient in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95d9860764cbd76c20e0a68128a28509
https://pubmed.ncbi.nlm.nih.gov/28011639
https://pubmed.ncbi.nlm.nih.gov/28011639
Autor:
Ian Spendlove, Ruhcha V. Sutavani
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781441979124
CD97 was identified as an early activation marker on T cells, having low expression on naive T cells. This is a common feature of molecules that have a role in T-cell function. It was subsequently identified as a ligand for CD55, which has been previ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f103b038bc00f5cb5b944184e6404621
https://doi.org/10.1007/978-1-4419-7913-1_12
https://doi.org/10.1007/978-1-4419-7913-1_12
